Colliers Securities analyst Kyle Bauser reiterated a Hold rating on Chembio Diagnostics (CEMI – Research Report) today. The company's shares closed last Thursday at $0.92, close to its 52-week low of $0.80. According to TipRanks.com, Bauser has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -6.8% and a 35.1% success rate. Bauser covers the Healthcare sector, focusing on stocks such as Apollo Medical Holdings, Semler Scientific, and Impedimed Limited. The word on The Street in general, suggests a Hold analyst consensus rating for Chembio Diagnostics.
https://www.tipranks.com/news/blurbs/colliers-securities-reiterates-their-hold-rating-on-chembio-diagnostics-cemi?utm_source=advfn.com&utm_medium=referral
Chembio Diagnostics (NASDAQ:CEMI)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more Chembio Diagnostics Charts.
Chembio Diagnostics (NASDAQ:CEMI)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more Chembio Diagnostics Charts.